MedPath

the Related Factors of Bariatric Surgery on Lipidemia

Not Applicable
Conditions
Bariatric Surgery
Lipidemia
Interventions
Procedure: sleeve gastrectomy
Procedure: gastric bypass
Registration Number
NCT03689803
Lead Sponsor
First Affiliated Hospital of Jinan University
Brief Summary

Obesity and related metabolic diseases have become a chronic disease that is a threat to human health. Bariatric surgery can effectively and long-term reduce excess body weight and relieve related metabolic diseases, including type 2 diabetes. Laparoscopic gastric bypass surgery and laparoscopic sleeve gastrectomy are commonly used in bariatric surgery. Laparoscopic sleeve gastrectomy due to simple operation, good weight loss, and metabolic disease control effect, which is more widely used. However, there are several studies that show an increased chance of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Long-term gastroesophageal reflux may lead to Barrett's esophagus or esophageal cancer. Nowadays, the cause of gastroesophageal reflux disease after sleeve gastrectomy is not clear and precautionary measures are not precise.

In this study, prospective randomized controlled trials were conducted to explore the possible change of lipidemia after bariatric surgery and to explore ways to prevent bariatric surgery after bariatric surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria

-For the choice of surgical approach, numerous studies have shown that BMI ≧ 45, the general choice of gastric bypass surgery, BMI <45, you can choose sleeve gastrectomy. The remission rate for T2DM, sleeve gastrectomy has a good result for young patients with shorter duration. In the investigator's country, the BMI less than 45 is majorities.

Exclusion Criteria

-BMI<27.5

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lipidemiasleeve gastrectomy-
Lipidemiagastric bypass-
Primary Outcome Measures
NameTimeMethod
preoperative of choleaterolPreoperate

choleaterol in ml/dl

Postoperative of choleaterol at 3 months3 months

choleaterol in ml/dl

Postoperative of choleaterol at 6 months6 months

choleaterol in ml/dl

Postoperative of choleaterol at 1 year1 year

choleaterol in ml/dl

Secondary Outcome Measures
NameTimeMethod
Preoperative of triglyceridePreoperative

triglyceride in ml/dl

Postoperative of triglyceride at 3 months3 months

triglyceride in ml/dl

Postoperative of triglyceride at 6 months6 months

triglyceride in ml/dl

Postoperative of triglyceride at 1 year1 year

triglyceride in ml/dl

Trial Locations

Locations (1)

The frist affiliated hospital of Jinan University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath